Notably, overexpression of the IL-17 axis has been associated with a variety of diseases affecting the liver, such as hepatitis B and C, alcohol, primary biliary cholangitis, acute rejection in liver transplant, hepatocellular carcinoma, autoimmune hepatitis and primary sclerosing cholangitis [29]. Here, IL17A is linked to sclerosing cholangitis.